Ketamine Dosing Recommendations
For intraoperative analgesia in adults, administer ketamine at a maximum bolus dose of 0.5 mg/kg after anesthesia induction, optionally followed by continuous infusion of 0.125-0.25 mg/kg/h (maximum 0.5 mg/kg/h), stopping 30 minutes before surgery ends. 1
Intraoperative Analgesia (Adults)
The 2019 expert panel guidelines provide the most authoritative dosing for perioperative analgesia 1:
- Initial bolus: 0.5 mg/kg IV after anesthesia induction (administered post-induction to prevent psychodysleptic side effects)
- Continuous infusion: 0.125-0.25 mg/kg/h
- Maximum infusion rate: 0.5 mg/kg/h
- Timing: Stop infusion 30 minutes before end of surgery
Key indication: Reserved for two specific situations:
- Surgery with high risk of acute or chronic postoperative pain
- Patients with vulnerability to pain (especially those on long-term opioids or with opioid addiction)
Important caveat: Continuing ketamine postoperatively increases hallucination risk without significantly improving analgesia 1. The guidelines demonstrate moderate evidence for 24-hour pain reduction and 15 mg decrease in morphine consumption, with 30% reduction in chronic pain at 3 months (low evidence level).
Anesthesia Induction (Adults)
The FDA-approved dosing for anesthesia induction differs substantially from analgesic dosing 2:
Intravenous Route:
- Dose range: 1-4.5 mg/kg IV
- Average dose: 2 mg/kg produces 5-10 minutes of surgical anesthesia within 30 seconds
- Administration: Slowly over 60 seconds (rapid administration causes respiratory depression and enhanced vasopressor response)
- Alternative: 0.5 mg/kg/min as IV infusion
Intramuscular Route:
- Dose range: 6.5-13 mg/kg IM
- Typical dose: 9-13 mg/kg produces surgical anesthesia within 3-4 minutes, lasting 12-25 minutes
Maintenance of Anesthesia:
- Repeat boluses: One-half to full induction dose as needed
- Continuous infusion: 0.1-0.5 mg/minute (adults)
- Adjunct therapy: Combine with benzodiazepine to prevent emergence reactions
Critical safety requirement: The 100 mg/mL concentration must be diluted 1:1 with sterile water, normal saline, or D5W before IV administration 2.
Pediatric Dosing
The 2024 ESPA guidelines provide comprehensive pediatric recommendations 3:
Intraoperative Use:
- Bolus: 0.5 mg/kg as adjunct to opioids
- S-ketamine: Reduced dose of 0.25-0.5 mg/kg
- Continuous infusion: 0.1-0.2 mg/kg/h (maximum 0.4 mg/kg/h)
Breakthrough Pain (PACU):
- Ketamine: 0.5 mg/kg titrated to effect
- S-ketamine: 0.25-0.5 mg/kg titrated to effect
Procedural Sedation
Adults:
Research evidence supports subdissociative dosing for procedural sedation 4, 5:
- Dose: 0.5-1.0 mg/kg IV
- Success rate: 98.9% adequate sedation
- Adverse events: 21.7% (primarily recovery agitation at 13%, manageable with midazolam)
Important finding: Subdissociative ketamine (0.3 mg/kg) combined with propofol is safer than fentanyl (1.5 mcg/kg) with propofol, with 5.1 times lower odds of serious intrasedation events 5.
Pediatrics:
- Intramuscular: 4-5 mg/kg IM produces 93-100% adequate sedation 6
- Intravenous: 0.5-1.0 mg/kg IV, with 88% successfully sedated at ≤1 mg/kg 7
- Incremental dosing: Start with 0.5 mg/kg, add 0.25-0.5 mg/kg aliquots as needed (maximum 2 mg/kg total)
Critical Safety Considerations
Monitoring requirements 2:
- Continuous vital sign monitoring mandatory
- Emergency airway equipment immediately available
- Administer antisialagogue prior to induction (due to salivation risk)
- Patients must be NPO (ketamine not recommended otherwise)
Contraindications 2:
- Patients where blood pressure elevation constitutes serious hazard
- Known hypersensitivity to ketamine
Common pitfall: Tonic-clonic movements during ketamine anesthesia do not indicate inadequate depth and do not require additional dosing 2.
Genitourinary toxicity: With chronic off-label use, monitor for genitourinary pain and consider cessation if symptoms develop 2.
The dosing varies dramatically by indication—from 0.5 mg/kg for perioperative analgesia to 2 mg/kg for anesthesia induction—making context-specific dosing essential for safety and efficacy.